Sarah E. Conduit

Sarah E. Conduit

Auto-generated profile, based on publicly available information

Sarah E. Conduit

Cell Signalling, UCL Cancer Institute, University College London, London, UK.

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2017 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
BCBernadette Carroll
Bernadette Carroll
GNGlyn Nelson
Glyn Nelson
YRYoana Rabanal Ruiz
Yoana Rabanal Ruiz
OKOlena Kucheryavenko
Olena Kucheryavenko
NDNatasha A. Dunhill-Turner
Natasha A. Dunhill-Turner
VKViktor Korolchuk
Viktor Korolchuk
Mammalian target of rapamycin complex 1 (mTORC1) and cell senescence are intimately linked to each other and to organismal aging. Inhibition of mTORC1 is the best-known intervention to extend lifespan, and recent evidence suggests that clearance of senescent cells can also improve health and lifespan. Enhanced mTORC1 activity drives characteristic phenotypes of senescence, although the underlying mechanisms responsible for increased activity are not well understood. We have identified that in human fibroblasts rendered senescent by stress, replicative exhaustion, or oncogene activation, mTORC1 is constitutively active and resistant to serum and amino acid starvation. This is driven in part by depolarization of senescent cell plasma membrane, which leads to primary cilia defects and a resultant failure to inhibit growth factor signaling. Further, increased autophagy and high levels of intracellular amino acids may act to support mTORC1 activity in starvation conditions. Interventions to correct these phenotypes restore sensitivity to the mTORC1 signaling pathway and cause death, indicating that persistent signaling supports senescent cell survival.

24 May 2023 in Nature
Verified
Journal Article
Open access
PDF file
GGGrace Q. Gong
Grace Q. Gong
BBBenoit Bilanges
Benoit Bilanges
BABen Allsop
Ben Allsop
GMGlenn R. Masson
Glenn R. Masson
VRVictoria Roberton
Victoria Roberton
BVBart Vanhaesebroeck
Bart Vanhaesebroeck
Harnessing the potential beneficial effects of kinase signalling through the generation of direct kinase activators remains an underexplored area of drug development1,2,3,4,5. This also applies to the PI3K signalling pathway, which has been extensively targeted by inhibitors for conditions with PI3K overactivation, such as cancer and immune dysregulation. Here we report the discovery of UCL-TRO-1938 (referred to as 1938 hereon), a small-molecule activator of the PI3Kα isoform, a crucial effector of growth factor signalling. 1938 allosterically activates PI3Kα through a distinct mechanism by enhancing multiple steps of the PI3Kα catalytic cycle and causes both local and global conformational changes in the PI3Kα structure. This compound is selective for PI3Kα over other PI3K isoforms and multiple protein and lipid kinases. It transiently activates PI3K signalling in all rodent and human cells tested, resulting in cellular responses such as proliferation and neurite outgrowth. In rodent models, acute treatment with 1938 provides cardioprotection from ischaemia–reperfusion injury and, after local administration, enhances nerve regeneration following nerve crush. This study identifies a chemical tool to directly probe the PI3Kα signalling pathway and a new approach to modulate PI3K activity, widening the therapeutic potential of targeting these enzymes through short-term activation for tissue protection and regeneration. Our findings illustrate the potential of activating kinases for therapeutic benefit, a currently largely untapped area of drug development.

20 December 2016 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JDJennifer M. Dyson
Jennifer M. Dyson
SCSarah E. Conduit
Sarah E. Conduit
SFSandra J. Feeney
Sandra J. Feeney
SHSandra Hakim
Sandra Hakim
TDTia DiTommaso
Tia DiTommaso
CMChristina A. Mitchell
Christina A. Mitchell
Human ciliopathies, including Joubert syndrome (JBTS), arise from cilia dysfunction. The inositol polyphosphate 5-phosphatase INPP5E localizes to cilia and is mutated in JBTS. Murine Inpp5e ablation is embryonically lethal and recapitulates JBTS, including neural tube defects and polydactyly; however, the underlying defects in cilia signaling and the function of INPP5E at cilia are still emerging. We report Inpp5e−/− embryos exhibit aberrant Hedgehog-dependent patterning with reduced Hedgehog signaling. Using mouse genetics, we show increasing Hedgehog signaling via Smoothened M2 expression rescues some Inpp5e−/− ciliopathy phenotypes and “normalizes” Hedgehog signaling. INPP5E’s phosphoinositide substrates PI(4,5)P2 and PI(3,4,5)P3 accumulated at the transition zone (TZ) in Hedgehog-stimulated Inpp5e−/− cells, which was associated with reduced recruitment of TZ scaffolding proteins and reduced Smoothened levels at cilia. Expression of wild-type, but not 5-phosphatase-dead, INPP5E restored TZ molecular organization and Smoothened accumulation at cilia. Therefore, we identify INPP5E as an essential point of convergence between Hedgehog and phosphoinositide signaling at cilia that maintains TZ function and Hedgehog-dependent embryonic development.

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
OPOlga V. Plotnikova
Olga V. Plotnikova
SSSeongjin Seo
Seongjin Seo
DCDenny L. Cottle
Denny L. Cottle
SCSarah Conduit
Sarah Conduit
SHSandra Hakim
Sandra Hakim
ISIan M. Smyth
Ian M. Smyth
Mutations in Inositol Polyphosphate-5-phosphatase E (INPP5E) cause the ciliopathies known as Joubert and MORM Syndromes; however the role of INPP5E in cilia biology is not well understood. We describe an interaction between INPP5E and AURKA, a centrosomal kinase that regulates mitosis and ciliary disassembly, and show this interaction is important for primary cilia stability. Furthermore, AURKA phosphorylates and thereby increases INPP5E 5-phosphatase activity, which in turn promotes transcriptional down-regulation of AURKA, partly via an AKT-dependent mechanism. These findings establish the first direct link between AURKA and phosphoinositide signalling and suggest the function of INPP5E in cilia is at least partly mediated by its interactions with AURKA.

21 July 2012 in FEBS Letters
Verified
Journal Article
Open access
SCSarah E. Conduit
Sarah E. Conduit
JDJennifer M. Dyson
Jennifer M. Dyson
CMChristina A. Mitchell
Christina A. Mitchell
Phosphoinositides regulate numerous cellular events via the recruitment and activation of multiple lipid‐binding effector proteins. The precise temporal and spatial regulation of phosphoinositide signals by the co‐ordinated activities of phosphoinositide kinases and phosphatases is essential for homeostasis and development. Mutations in two inositol polyphosphate 5‐phosphatases, INPP5E and OCRL, cause the cerebrorenal syndromes of Joubert and Lowe's, respectively. INPP5E and OCRL exhibit overlapping phosphoinositide substrate specificity and subcellular localisation, including an association with the primary cilia. Here, we review recent studies that identify a new role for these enzymes in the regulation of primary cilia function. Joubert syndrome has been extensively linked to primary cilia defects, and Lowe's may represent a new class of ‘ciliopathy associated’ syndromes.

24 September 2020 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
SCSarah E. Conduit
Sarah E. Conduit
BVBart Vanhaesebroeck
Bart Vanhaesebroeck
Primary cilia are solitary signalling organelles projecting from the surface of most cell types. Although the ciliary membrane is continuous with the plasma membrane it exhibits a unique phospholipid composition, a feature essential for normal cilia formation and function. Recent studies have illustrated that distinct phosphoinositide lipid species localise to specific cilia subdomains, and have begun to build a ‘phosphoinositide map’ of the cilium. The abundance and localisation of phosphoinositides are tightly regulated by the opposing actions of lipid kinases and lipid phosphatases that have also been recently discovered at cilia. The critical role of phosphoinositides in cilia biology is highlighted by the devastating consequences of genetic defects in cilia-associated phosphoinositide regulatory enzymes leading to ciliopathy phenotypes in humans and experimental mouse and zebrafish models. Here we provide a general introduction to primary cilia and the roles phosphoinositides play in cilia biology. In addition to increasing our understanding of fundamental cilia biology, this rapidly expanding field may inform novel approaches to treat ciliopathy syndromes caused by deregulated phosphoinositide metabolism.